Mettis Global News
Mettis Global News

DGKC profit more than doubles year-on-year

DGKC profit more than doubles year-on-year
Facebook
Twitter
LinkedIn
WhatsApp

April 29, 2025 (MLN): D.G. Khan Cement Company Limited (PSX: DGKC) has reported a stellar 131% year-on-year increase in its consolidated profit for the nine months ended March 31, 2025, reaching Rs6.05 billion compared to Rs2.63bn in the same period last year.

Earnings per share (EPS) surged to Rs13.21 from Rs5.37, reflecting a growth of 146%.

Sales revenue rose by 12.5% to Rs60.22bn from Rs53.51bn in the corresponding period of the previous year. Despite a 6.2% increase in cost of sales, gross profit jumped by nearly 40% to Rs14.09bn, showcasing improved operational efficiency.

On the expense side, administrative costs increased by 8.7% to Rs1.09bn, while selling and distribution expenses saw a steep 81.6% rise, reaching Rs2.94bn. Other expenses also spiked significantly to Rs569.5 million from just Rs6.4m last year.

Additionally, changes in the fair value of biological assets contributed Rs318.2m, marking a 21.1% increase.

A key contributor to the profit surge was a 45.7% decline in finance costs, which dropped to Rs3.53bn from Rs6.5bn.

This reduction in borrowing costs significantly bolstered pre-tax earnings, which more than doubled to Rs9.22bn from Rs3.95bn in the prior year.

After accounting for a 6.8% rise in levy charges and a 139.6% jump in taxation, the net profit stood at Rs6.05bn. Of this, Rs5.79bn was attributable to equity holders of the parent, while the remaining Rs264m was attributed to non-controlling interests.

Consolidated Statement of Profit and Loss For The Nine Month Ended March 31, 2025 (Rupees '000)
Category Mar-25 Mar-24 %Change
Sales 60,215,243 53,509,872 12.53%
Cost of Sales (46,128,277) (43,428,196) 6.22%
Gross Profit 14,086,966 10,081,676 39.73%
Administrative Expenses (1,094,895) (1,006,955) 8.73%
Selling and Distribution Expenses (2,940,871) (1,619,542) 81.59%
Other Expenses (569,547) (6,419) 8772.83%
Changes in Fair Value of Biological Assets 318,163 262681 21.12%
Other Income 3,321,431 262,681 1164.44%
Finance Cost (3,530,353) (6,502,042) -45.70%
Profit Before Taxation and Levy 9,661,997 4,361,450 121.53%
Levy (443,706) (415,339) 6.83%
Profit Before Income Tax 9,218,291 3,946,111 133.60%
Taxation (3,165,394) (1,321,085) 139.61%
Profit for the Period 6,052,897 2,625,026 130.58%
Attributable to:      
– Equity Holders of the Parent 5,788,668 2,352,825 146.03%
– Non-Controlling Interest 264,229 272,201 -2.93%
Earnings Per Share (Basic and Diluted – Rs.) 13.21 5.37 146.00%

Copyright Mettis Link News

Posted on: 2025-04-29T09:24:32+05:00